PRME News and Press, First Trust Heitman Global Prime Real Estate ETF

2024-06-20 16:14:49 ET Summary We take our first look at gene editing concern Prime Medicine, Inc., whose stock was recently upgraded by Citigroup. The company has an extensive set of potential candidates in pre-clinical research and just advanced its first gene therapy asset in c...

2024-06-07 12:02:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-05-26 23:48:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-05-22 17:10:41 ET Gainers: Chicken Soup for the Soul  ( CSSEN ) +18% . Signature Bank ( OTC:SBNY ) +7% . PetMed Express ( PETS ) +6% . Prime Medicine ( PRME ) +6% . Sana Biotechnology ( SANA ) +5% . Losers: Cyto...

2024-05-21 17:03:16 ET Gainers: Urban Outfitters ( URBN ) +8% . Humacyte ( HUMA ) +5% . Hesai Group ( HSAI ) +5% . LifeMD ( LFMD ) +4% . Prime Medicine ( PRME ) +2% . Losers: ViaSat ( VSAT ) -11% . LifeStance ...

2024-05-17 06:27:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips The ARK Innovation ETF (NYSEARCA: ARKK ) has come under the spotlight recently, and there are three Cathie Wood stocks to buy with strong buy ratings for investors to consider in Ma...

2024-05-17 06:15:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips With innovation, millions of retiring baby boomers, demand for better care, patent cliffs, gene-editing, massive interest in weight-loss treatments, and an increase in mergers, biotech stocks...

2024-05-17 05:20:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-05-16 11:23:36 ET More on Prime Medicine FDA clears Prime Medicine to begin gene therapy clinical testing Seeking Alpha’s Quant Rating on Prime Medicine Historical earnings data for Prime Medicine Financial information for Prime Medicine ...

2024-05-15 21:30:02 ET Citigroup analyst issues BUY recommendation for PRME on May 15, 2024 07:44PM ET. PRME was trading at $6.76 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 3 - Buy, 1 - Hold recommen...